Premier Inc.
04/02/2026 | Press release | Distributed by Public on 04/02/2026 09:14
Iran war and drug supplies: Don’t panic, but pay attention
*:last-child]:mb-0 [&>*:last-child]:pb-0 [&>p]:font-normal text-left [&>.prm-button-bar]:justify-start [&_.portable-text-link]:font-semibold [&_.portable-text-link]:underline [&_.prm-button-bar_a]:no-underline [&_li]:text-light-gray [&_p]:text-light-gray">
Chief Healthcare Executive explores how the war in Iran could affect pharmaceutical supply chains, with experts advising providers to monitor developments but avoid premature stockpiling. The article includes insights from Kyle MacKinnon, senior director of operational excellence at Premier, and Mark Hendrickson, director of supply chain policy at Premier, who note that hospitals currently have safety stock in place and widespread disruptions are not expected in the near term. However, they caution that prolonged conflict could increase costs and create downstream supply challenges.
Read the full story on Chief Healthcare Executive.
Premier Inc. published this content on April 02, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 02, 2026 at 15:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]